Thursday December 5, 2019

Open Orphan sets sights on €100m valuation

Ian Guider

Markets Editor

26th May, 2019

Open Orphan is targeting a valuation of €100 million in the next year after it completes the reverse takeover of drug services company Venn Life Sciences.

Open Orphan is currently in the middle of a fundraising round with the company seeking a modest amount of new cash, understood to be less than €10 million, from investors, according to market sources. The company and its advisers, IBI Corporate Finance, met with potential new investors in London...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader



Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.



€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.




90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

Mortgage gouging by banks does not serve society well

Matt Cooper | 2 weeks ago